|
Market Closed -
Nasdaq
21:30:00 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.3350 USD | +0.51% |
|
-5.87% | -75.00% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.25M | - | - | - | - | - |
| 69.4B | |||||
| 57.62B | |||||
| 57.24B | |||||
| 44.03B | |||||
| 43.65B |
- Stock Market
- Stocks
- SNGX Stock
- Charts Soligenix, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
